with recent drug trials comming up negative my concern is gilead going forward.Do they have sufficiant revenue and pipeline to justify continued investment.Is this recent dip a buying opportunity ?
The company just got a set back.....that's why thestock came down from $56 to about $44. But I thinkit has plenty of cash..... and hte sales are doingwell.How lower the stock could go I do not know....butif dips below $40... I would be a net buyer.I have owned the stock since 2002!PHOINIX20The Eternal Bird.
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |